Merck CEO Rob Davis Talks Winrevair Approval
Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.
See omnystudio.com/listener for privacy information.
You May Also Like

Entendez-vous l'éco ?
France Culture

Earn Your Happy
Lori Harder | YAP Media
Wake Up to Money
BBC Radio 5 Live

investir.ch
investir.ch

Faßnacht, Freiheit & Finanzen: Der Strategische Vermögenskompass für Selbständige & Unternehmer
Diego Faßnacht, CFA

Business English from All Ears English
Lindsay McMahon

Stories and Strategies with Curzon Public Relations
Stories and Strategies https://storiesandstrategies.ca/

The Spend Life Well Show
ClearVista Financial

KryptoSpace
Petr Lukáč

Small Business Casual
Emily Aborn
Community discussion